Synthesis, structure and quantitative structure-activity relationships of σ receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines-Reference-Cited by-同舟云学术

Synthesis, structure and quantitative structure-activity relationships of σ receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines

Published:1997-08 Issue:8 Volume:5 Page:1675-1683
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Fujimura Ken-ichi,Matsumoto Junzo,Niwa Masashi,Kobayashi Tadayuki,Kawashima Yoichi,In Yasuko,Ishida Toshimasa

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference38 articles.

1. Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus

2. Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig

3. Sigma Receptors;Wolfe,1994

4. Functional assessment and partial characterization of [3H](+)-pentazocine binding sites on cells of the immune system

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography;Journal of Medicinal Chemistry;2021-04-27

2. Wildtype σ1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity;Journal of Biological Chemistry;2020-12

3. Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases;Journal of Medicinal Chemistry;2020-10-28

4. Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression;Scientific Reports;2020-06-08

5. The sigma receptor ligand N-phenylpropyl-N′-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice;Psychopharmacology;2019-12-10